Cargando…

Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation

Enhancer of Zeste homologue 2 (EZH2) overexpression is associated with tumor proliferation, metastasis, and poor prognosis. Targeting and inhibition of EZH2 is a potentially effective therapeutic strategy for head and neck squamous cell carcinoma (HNSCC). We analyzed EZH2 mRNA expression in a well-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mochizuki, Daiki, Misawa, Yuki, Kawasaki, Hideya, Imai, Atsushi, Endo, Shiori, Mima, Masato, Yamada, Satoshi, Nakagawa, Takuya, Kanazawa, Takeharu, Misawa, Kiyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320890/ https://www.ncbi.nlm.nih.gov/pubmed/30469511 http://dx.doi.org/10.3390/ijms19123707

Ejemplares similares

Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2016)

Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2017)

Epigenetic modification of SALL1 as a novel biomarker for the prognosis of early stage head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

Association of TET3 epigenetic inactivation with head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

Neuropeptide receptor genes GHSR and NMUR1 are candidate epigenetic biomarkers and predictors for surgically treated patients with oropharyngeal cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

The neuropeptide genes SST, TAC1, HCRT, NPY, and GAL are powerful epigenetic biomarkers in head and neck cancer: a site-specific analysis
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis
por: Misawa, Kiyoshi, et al.
Publicado: (2017)

Genes Located on 18q23 Are Epigenetic Markers and Have Prognostic Significance for Patients with Head and Neck Cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2019)

Primary combined small and squamous cell carcinoma of the hypopharynx: A case report
por: MISAWA, KIYOSHI, et al.
Publicado: (2016)

Long interspersed nuclear element 1 hypomethylation has novel prognostic value and potential utility in liquid biopsy for oral cavity cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

5-Hydroxymethylcytosine and ten-eleven translocation dioxygenases in head and neck carcinoma
por: Misawa, Kiyoshi, et al.
Publicado: (2019)

Aberrant Methylation Inactivates Somatostatin and Somatostatin Receptor Type 1 in Head and Neck Squamous Cell Carcinoma
por: Misawa, Kiyoshi, et al.
Publicado: (2015)

G Protein-Coupled Receptor Genes, PTGDR1, PTGDR2, and PTGIR, Are Candidate Epigenetic Biomarkers and Predictors for Treated Patients with HPV-Associated Oropharyngeal Cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Late recurrence of breast carcinoma metastasis to the hypopharynx: a case report
por: Izumi, Chisako, et al.
Publicado: (2016)

Analysis of Site-Specific Methylation of Tumor-Related Genes in Head and Neck Cancer: Potential Utility as Biomarkers for Prognosis
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

Human papillomavirus-associated small cell carcinoma/neuroendocrine carcinoma of the oropharynx: a report of two cases
por: Misawa, Kiyoshi, et al.
Publicado: (2016)

Identification of novel methylation markers in HPV-associated oropharyngeal cancer: genome-wide discovery, tissue verification and validation testing in ctDNA
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Telomere shortening in head and neck cancer: association between DNA demethylation and survival
por: Yamada, Satoshi, et al.
Publicado: (2021)

Aberrant epigenetic regulation in clear cell sarcoma of the kidney featuring distinct DNA hypermethylation and EZH2 overexpression
por: Karlsson, Jenny, et al.
Publicado: (2016)

Establishment of epigenetic markers to predict irradiation efficacy against oropharyngeal cancer
por: Kurokawa, Tomoya, et al.
Publicado: (2020)

Rare case of malignant transformation of recurrent respiratory papillomatosis associated with human papillomavirus type 6 infection and p53 overexpression
por: Kanazawa, Takeharu, et al.
Publicado: (2013)

Epigenetic inactivation of galanin receptors in salivary duct carcinoma of the parotid gland: Potential utility as biomarkers for prognosis
por: Kanazawa, Takeharu, et al.
Publicado: (2018)

G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?
por: Kanazawa, Takeharu, et al.
Publicado: (2015)

DNA Methylation and HPV-Associated Head and Neck Cancer
por: Nakagawa, Takuya, et al.
Publicado: (2021)

Diagnosis of Ion-Exchange Resin Depositions in Paraffin Sections Using Corrective Light and Electron Microscopy-NanoSuit Method
por: Ooishi, Mako, et al.
Publicado: (2021)

Association between human papillomavirus particle production and the severity of recurrent respiratory papillomatosis
por: Yamada, Satoshi, et al.
Publicado: (2023)

RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker
por: Misawa, A, et al.
Publicado: (2009)

Aberrant fetal macrophage/microglial reactions to cytomegalovirus infection
por: Sakao-Suzuki, Makiko, et al.
Publicado: (2014)

Single injection of basic fibroblast growth factor to treat severe vocal fold lesions and vocal fold paralysis
por: Kanazawa, Takeharu, et al.
Publicado: (2015)

Indwelling voice prosthesis insertion after total pharyngolaryngectomy with free jejunal reconstruction
por: Fukushima, Hirofumi, et al.
Publicado: (2017)

Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome
por: Xu, Feng, et al.
Publicado: (2016)

EMP3 Overexpression in Primary Breast Carcinomas is not Associated with Epigenetic Aberrations
por: Zhou, Wei, et al.
Publicado: (2009)

Aberrant promoter hypermethylation of miR-335 and miR-145 is involved in breast cancer PD-L1 overexpression
por: Hajibabaei, Sara, et al.
Publicado: (2023)

Aberrant CpG Islands Hypermethylation Profiles in Malignant Gliomas
por: Kim, Kwang Ryeol, et al.
Publicado: (2014)

HOXA11 gene is hypermethylation and aberrant expression in gastric cancer
por: Bai, Yinguo, et al.
Publicado: (2014)

Aberrant expression of ALK and EZH2 in Merkel cell carcinoma
por: Veija, Tuukka, et al.
Publicado: (2017)

Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells
por: Uehara, Takayuki, et al.
Publicado: (2014)

The role of aberrant promoter hypermethylation of DACT1 in bladder urothelial carcinoma
por: Cheng, Huan, et al.
Publicado: (2012)

Genomic insights into cancer-associated aberrant CpG island hypermethylation
por: Sproul, Duncan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_aof15lf07set4fgl6i3kf4k31q